top of page
A L T I T U D E
Life Science Ventures
Companies in the News
eFFECTOR’s Zotatifin Demonstrates in vitro Anti-SARS-CoV-2 Activity in Independent International Stu
SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., today announced that preliminary results from an independent...
Apr 30, 2020
eFFECTOR’s Zotatifin (eFT226) Inhibited Tumor Growth and Caused Tumor Regression Across Diverse Rece
Study Presented in Virtual Session at AACR Annual Meeting Provides Evidence of Potential for Zotatifin to Drug an Important Class of...
Apr 27, 2020
GlaxoSmithKline injects US$250mln into US biotech Vir in coronavirus treatment collaboration
Vir's has two candidates that have proved highly potent in neutralising SARS-CoV-2 in live virus-cellular assays GlaxoSmithKline PLC...
Apr 6, 2020
bottom of page